Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial.
about
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Treatment of advanced gastroin ...... n human, first in class trial.
@en
Treatment of advanced gastroin ...... n human, first in class trial.
@nl
type
label
Treatment of advanced gastroin ...... n human, first in class trial.
@en
Treatment of advanced gastroin ...... n human, first in class trial.
@nl
prefLabel
Treatment of advanced gastroin ...... n human, first in class trial.
@en
Treatment of advanced gastroin ...... n human, first in class trial.
@nl
P2093
P2860
P356
P1433
P1476
Treatment of advanced gastroin ...... n human, first in class trial.
@en
P2093
Christiane Bruns
Christine Günther
Christoph Salat
Dominik P Modest
Gerald Grütz
Hanno Niess
Jobst C von Einem
Julian W Holch
Marlies Michl
Martin Angele
P2860
P304
80156-80166
P356
10.18632/ONCOTARGET.20964
P407
P577
2017-09-16T00:00:00Z